Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanton R Mehr

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The American Journal of Managed Care|June 4, 2013
Applying accountable care to oncology: developing an oncology ACOStanton R Mehr
American Health & Drug Benefits|April 12, 2016
Payer Perspectives on PCSK9 Inhibitors: A Conversation with Stephen Gorshow, MD, and James T. Kenney, RPh, MBAStanton R Mehr
The American Journal of Managed Care|January 26, 2015
Attacking complications to kidney problems in diabetes: atrial fibrillation and resistant hypertensionStanton R Mehr
The American Journal of Managed Care|January 26, 2015
The link between a common type of bariatric surgery and increased alcohol useStanton R Mehr
The American Journal of Managed Care|January 1, 2015
Can gastric bypass surgery be a cure for diabetes mellitus?Stanton R Mehr
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Will the emerging private-label market access channel help or hinder biosimilar market access?Stanton R Mehr
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Sustaining competition for biosimilars on the pharmacy benefit: Use it or lose itStanton R Mehr
Managed Care Interface|February 4, 2006
Is the employer-based health coverage system a foundation or a relic?Stanton R Mehr
The American Journal of Managed Care|June 4, 2013
Value-based contracting for pharmaceuticals: getting ready for prime time?Stanton R Mehr
American Health & Drug Benefits|May 4, 2017
Pharmaceutical Patent Litigation and the Emerging Biosimilars: A Conversation with Kevin M. Nelson, JDStanton R Mehr
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The American Journal of Managed Care|June 4, 2013
Applying accountable care to oncology: developing an oncology ACOStanton R Mehr
American Health & Drug Benefits|April 12, 2016
Payer Perspectives on PCSK9 Inhibitors: A Conversation with Stephen Gorshow, MD, and James T. Kenney, RPh, MBAStanton R Mehr
The American Journal of Managed Care|January 26, 2015
Attacking complications to kidney problems in diabetes: atrial fibrillation and resistant hypertensionStanton R Mehr
The American Journal of Managed Care|January 26, 2015
The link between a common type of bariatric surgery and increased alcohol useStanton R Mehr
The American Journal of Managed Care|January 1, 2015
Can gastric bypass surgery be a cure for diabetes mellitus?Stanton R Mehr
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Will the emerging private-label market access channel help or hinder biosimilar market access?Stanton R Mehr
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Sustaining competition for biosimilars on the pharmacy benefit: Use it or lose itStanton R Mehr
Managed Care Interface|February 4, 2006
Is the employer-based health coverage system a foundation or a relic?Stanton R Mehr
The American Journal of Managed Care|June 4, 2013
Value-based contracting for pharmaceuticals: getting ready for prime time?Stanton R Mehr
American Health & Drug Benefits|May 4, 2017
Pharmaceutical Patent Litigation and the Emerging Biosimilars: A Conversation with Kevin M. Nelson, JDStanton R Mehr
Pageof 4